While a common misconception about endometriosis is that it is simply a "menstruation disease," EndoFound says it's in fact a ...

First-line PARP inhibitor maintenance after platinum chemotherapy reduces progression risk in certain patients with ovarian ...

Inherited changes in the tumor suppressor genes BRCA1 and BRCA2, raise lifetime risk substantially. For ovarian cancer, the ...

A long running study has found that Rhythm Biosciences’ geneType ovarian cancer risk model is twice as effective at ...

SAN ANTONIO — Thanksgiving is a holiday that is centered around gatherings, including food, family, and friends. Meet the San ...

AJMC Insights Series features Kathleen Moore, MD, MS, a gynecologic oncologist and expert in ovarian cancer treatment. Dr Moore discusses various aspects of novel therapies for ovarian cancer ...

Mirvetuximab soravtansine (MIRV; Elahere; AbbVie) demonstrated significant efficacy and an acceptable safety profile in the treatment of recurrent ovarian cancer, showing particular promise in ...

A gentle ache, a missed period, a feeling of being off; women often carry on through symptoms that could signal deeper ...

How Does Zejula Work in Advanced Ovarian Cancer? In platinum-based chemotherapy, the platinum in the medicine binds to the genetic material (DNA) of cancer cells. This damages the cancer cells and ...

Ovarian cancer is often advanced at the time of diagnosis. Debulking is a surgical procedure that may prevent or delay disease progression. Debulking is a type of surgery that removes as many ovarian ...

How Does Lynparza Work for Ovarian Cancer? Lynparza is a type of medicine known as poly (ADP-ribose) polymerase (PARP) inhibitor. PARP is a certain protein that helps cancer cells survive and grow. It ...

A 14-year-old from Derbyshire is preparing for a Christmas to remember after completing her treatment for cancer. Izzy was ...